Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, open-world, and non-destructive behavior, and the description adds substantial transparency beyond that: it discloses the USPTO API sunset with soft-fail behavior, the GDELT→GNews fallback, the expected empty FDA section for non-biologic companies, and the meaning of sources_used/sources_failed. It also pre-empts misreading empty results as bugs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but the tool is genuinely complex — it fans out across many sources and returns many fields. It front-loads the purpose with examples and routes the agent to the right choice, then systematically enumerates outputs. A slight deduction for density: it is a large single block where some repeated source mentions could be tightened.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description fully carries the burden of explaining return values — and it does, covering resolved identity, recent_filings with URI shape, fundamentals ordering, patents, contracts, FDA products, hiring, news fallback, LEI, and the sources_used/sources_failed pair. Edge cases like missing FDA data and soft-failed patents are explicitly addressed.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, yet the description still adds real value: it explains that type 'company' and 'ticker' are interchangeable, gives exact value examples including zero-padded CIK, and clarifies what happens when a name resolves vs. a private company. The resolved_from/resolved_to and 'not a bare failure' notes are meaningfully beyond the schema text.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb+resource: it builds a "full cross-source profile of a US public company in ONE parallel call," and immediately grounds it with concrete user phrasings like "tell me about X" and "company profile for Microsoft." It clearly distinguishes itself from narrower single-pack lookups by insisting this is the holistic, fan-out alternative.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance: "ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view." It also enumerates acceptable inputs (ticker, CIK, company name) and explains the private-company edge case, so an agent knows the runnable scope and the expected non-failure outcome when resolution fails.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-duplicates, while deep_research, validate_claim, and bet_research blur the same routing/grounding line. The polymarket_* family also has five tools covering edges, arbitrage, fill risk, and edge decay with significant functional overlap, making misselection likely despite very detailed descriptions.

Naming Consistency2/5

Naming mixes verb_noun tools (get_pair, compare_entities, suggest_questions) with noun-style tools (entity_profile, recent_changes, bet_research) and bare verbs (remember, recall, forget). The polymarket_ and pipeworx_ prefixes add some structure, but overall the naming is inconsistent and doesn't follow a predictable pattern.

Tool Count1/5

The server is named 'exchangerate' but exposes 33 tools, only two of which (get_pair, get_rates) relate to exchange rates. Even as a general data platform 33 tools is at the extreme high end, and for the stated server purpose the count is wildly inappropriate.

Completeness1/5

For an exchange-rate server, the surface is severely incomplete: there is no historical rate lookup, no amount conversion, no supported-currency listing, and no rate-change monitoring. The actual tool content covers a broad research platform, but that is entirely mismatched with the server name, leaving the implied exchange-rate domain almost completely uncovered.